What is Nor Consult?
Nor Consult operates as a specialized clinical research organization and strategic consulting partner, providing essential support to life sciences entities navigating the complex pathways of FDA and EMA approvals. The firm distinguishes itself through a deep focus on high-stakes therapeutic domains, including cardiovascular, neurovascular, orthopedic, and wound management. By leveraging a team of senior experts, Nor Consult delivers precision-driven regulatory confidence and efficient study execution. This operational model is designed to mitigate risk and optimize cost structures for sponsors, effectively bridging the gap between clinical innovation and commercial viability in the global medical device and pharmaceutical markets.
How much funding has Nor Consult raised?
Nor Consult has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nor Consult
PPP
Public-Private Partnership
What's next for Nor Consult?
Following this major strategic investment, Nor Consult is poised to scale its operational capacity and deepen its expertise in regulatory affairs. The firm will likely prioritize the enhancement of its clinical research infrastructure to meet the increasing demand for rigorous, data-backed evidence required by global regulatory bodies. By focusing on high-growth therapeutic areas, the company aims to solidify its reputation as a premier partner for sponsors seeking to navigate the complexities of drug and medical device development. Future growth initiatives will likely center on expanding its global reach and integrating advanced analytical tools to further streamline the path to market approval for its diverse client base.
See full Nor Consult company page
